Among the 11 serum tumor markers, AFP, CA125, CA19‐9, CA242, CEA, Ferritin, NSE and HE4 showed elevated levels and CA15‐3, HGH, and β‐HCG showed reduced levels in ovarian cancer patients (Table 2). This evidence concerns the gene GH1 and neoplasm.